Physician
Lagatta, Lorine
Lagatta, Lorine was paid $447K by Medicaid between Oct 2021 and Jun 2022, across 8 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 61% of everything it billed.
33Billing provider infoLAGATTA, LORINE
SAN ANTONIO, TX 78251
SAN ANTONIO, TX 78251
33aNPI1588722201assigned 12/05/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$447K
24GClaims10,155
24DCodes billed8
24AFirst – last monthOct 2021 – Jun 2022
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Texas
Rank by total paid#17 of 97
Median peer was paid$24K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,412 | $60K | |
| 2022 | 8,743 | $386K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 61% | 3,755 | 2,181 | $274K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 19% | 3,531 | 2,073 | $86K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 14% | 2,630 | 1,643 | $61K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.2% | 166 | 45 | $23K |
| 88312 | <1% | 21 | 17 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 22 | 18 | $759.05 |
| 88311 | <1% | 14 | 13 | $181.13 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | 12 | $150.22 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.